Barbara J. Schwarzentraub Power - 31 May 2024 Form 4 Insider Report for CONMED Corp (CNMD)

Role
Director
Signature
/s/ Thomas Fistek for Barbara J. Schwarzentraub by Power of Attorney
Issuer symbol
CNMD
Transactions as of
31 May 2024
Net transactions value
$0
Form type
4
Filing time
04 Jun 2024, 21:05:17 UTC
Previous filing
10 May 2024
Next filing
04 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $0 +302 +8.5% $0.000000 3,865 31 May 2024 Direct
holding CNMD Common Stock 1,442 31 May 2024 by The Barbara J. Schwarzentraub Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Rsus (restricted Stock Units) Options Exercise $0 -302 -100% $0.000000* 0 31 May 2024 Common Stock 302 $0.000000 Direct F1
transaction CNMD Options To Purchase Common Stock Award $0 +5,503 $0.000000 5,503 03 Jun 2024 Common Stock 5,503 $77.18 Direct F2
transaction CNMD Rsus (restricted Stock Units) Award $0 +479 $0.000000 479 03 Jun 2024 Common Stock 479 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2 The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.